4//SEC Filing
Claiborne Cary J 4
Accession 0001213900-24-106119
CIK 0001513525other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:47 PM ET
Size
5.6 KB
Accession
0001213900-24-106119
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-05+350,000→ 350,000 totalExercise: $1.15Exp: 2034-12-04→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing December 5, 2024.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001370930
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:47 PM ET
- Size
- 5.6 KB